SP
SUPERNUS PHARMACEUTICALS INC
SUPN· Health Care· PharmaceuticalsS&P 600
Close · 26/10/2026
40.77
1D
+0.17%52-week range
37.54 – 59.68
Volume
9,30,900.00
Price history
SUPN
25/09/2026 to 26/10/2026
O 40.72 H 40.87 L 39.58
1W+2.33%
1M-4.43%
3M-14.58%
6M-17.57%
1Y-21.63%
3Y+71.45%
5Y+32.89%
MAX+62.50%
Fundamentals
as of 26/10/2026- Market cap
- $2.37B
- Shares out
- 58.13M
- P/E (forward)
- 9.51
- EPS (trailing)
- -1.89
- Dividend yield
- 0.00%
- Beta
- 0.55
- Profit margin
- -13.23%
- P/B
- 2.30
- Return on equity
- -10.66%
SEC financial statements
56 quarterly and 16 annual periods through 30/06/2026.
Details
- Ticker
- SUPN
- Index
- SP600
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 26/10/2026.
Tracked by Congress
2 filers · 1 on watchlist · 3 buys · 2 sells · D: 5
- 03/03/2026Gilbert CisnerosBuySupernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 11/12/2025Gilbert CisnerosBuySupernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 09/10/2025Gilbert CisnerosSell+Supernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 24/03/2025Gilbert CisnerosBuySupernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 23/12/2022Josh GottheimerWSell+Supernus Pharmaceuticals, Inc.$1,001–$15,000